| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gabriele Di Carlo | Q61218128 |
| Matteo Saccucci | Q64965337 | ||
| Antonella Polimeni | Q59033045 | ||
| P2093 | author name string | Alessandro Salucci | |
| Maurizio Bossù | |||
| Francesca Giovarruscio | |||
| P2860 | cites work | Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease | Q68086434 |
| Oral mucosal lesions in systemic lupus erythematosus--a clinical, histopathological and immunopathological study | Q70326235 | ||
| HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form | Q72010167 | ||
| Fungal load and candidiasis in Sjögren's syndrome | Q73939577 | ||
| Evaluation of the concordance of sialometry and salivary glands scintigraphy in dry mouth patients | Q80135321 | ||
| Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies | Q80174631 | ||
| Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate | Q80494215 | ||
| Increasing prevalence of coeliac disease over time | Q81458628 | ||
| Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment | Q30234992 | ||
| Enamel hypoplasia in coeliac children: a potential clinical marker of early diagnosis | Q33278523 | ||
| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients | Q33357081 | ||
| Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management. | Q33489552 | ||
| Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome | Q33578726 | ||
| American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort | Q34260251 | ||
| The classification of glomerulonephritis in systemic lupus erythematosus revisited | Q34293066 | ||
| Durable remission of pemphigus with a fixed-dose rituximab protocol | Q34402588 | ||
| Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease | Q35906926 | ||
| Systemic lupus erythematosus: a review for dentists. | Q37009093 | ||
| Oral pemphigus vulgaris: a case report with review of the literature | Q37279707 | ||
| Sjögren's syndrome of the oral cavity. Review and update | Q37418890 | ||
| Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management | Q37765598 | ||
| Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. | Q38049753 | ||
| Immune-mediated diseases: what can be found in the oral cavity? | Q38290659 | ||
| Oral mucosal manifestations of autoimmune skin diseases | Q38539169 | ||
| Future therapies for pemphigus vulgaris: Rituximab and beyond | Q38705147 | ||
| Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. | Q38807791 | ||
| Orofacial manifestations in patients with inflammatory rheumatic diseases | Q39037780 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| Oral manifestations of lupus erythematosus | Q40212922 | ||
| Use of 0.1% tacrolimus ointment in patients with various forms of lupus erythematosus | Q44049155 | ||
| The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus | Q44099092 | ||
| Sjögren's syndrome association with HLA-Dw3 | Q44495433 | ||
| Topical and systemic medications for the treatment of primary Sjögren's syndrome. | Q44498935 | ||
| Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany | Q44594498 | ||
| Spectrum of orocutaneous disease associations: Immune-mediated conditions | Q47655817 | ||
| Treatment of cutaneous lupus erythematosus: current practice variations. | Q48065233 | ||
| Altered transcription of inflammation-related genes in dental pulp of coeliac children | Q48123853 | ||
| Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris. | Q48256118 | ||
| Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid | Q48279461 | ||
| Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. | Q50910869 | ||
| Behçet's disease: New insights into pathophysiology, clinical features and treatment options. | Q52598557 | ||
| Sjögren's syndrome | Q55921808 | ||
| Relationship between salivary flow rates and Candida counts in subjects with xerostomia | Q56970582 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune disease | Q8084905 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 6061825 | |
| P577 | publication date | 2018-05-27 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management | |
| P478 | volume | 2018 |
| Q89866046 | A cohort study: The Association Between Autoimmune Disorders and Leptospirosis |
| Q64965289 | Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators? |
| Q92479184 | Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin |
Search more.